Injectable artesunate field testing report
WHO recommends parenteral artesunate in preference to quinine for the treatment of severe P. falciparum malaria in adults and children. Intravenous injection is the preferred route of administration although intramuscular can also be given. The challenge however will be to ensure that healthcare providers (mainly nurses) fully understand how to prepare and administer the product. MMV has developed training materials to illustrate these steps and facilitate the correct use of the product. This documents reports on the first stages of testing these materials to enhance comprehension, relevance/appropriateness to the context and attractiveness.